Trade Opportunity
Export Pharmaceuticals from Latvia to Belgium under the EU-Mercosur Agreement 2026. Reduced tariffs and preferential access to a market of 780 million consumers.
📌 Why This Matters
Supply chain optimization becomes easier with harmonized regulations.
💰 Cost Savings: Average tariff reduction of 35% on industrial goods.
🔗 Related Opportunities
📌 Why This Matters
With 780 million consumers, this market offers unprecedented opportunities.
📊 Key Statistics: Combined GDP of €18 trillion, bilateral trade worth €140 billion annually.